Biotechnology and pharma industries will receive logistics and manufacturing services from the two organizations Cryoport, a supply-chain service company, and SK pharmteco, a contract development and manufacturing organization, announced on Sept. 25, 2024, that they are partnering to offer combined logistics and manufacturing services to bio/pharmaceutical companies. Cryoport will
FDA approved EBGLYSS (lebrikizumab-lbkz) for moderate-to-severe atopic dermatitis that is difficult to treat with topicals On September 13, 2024, the FDA approved Eli Lilly and Company’s EBGLYSS (lebrikizumab-lbkz), a specific inhibitor of interleukin 13 (IL-13), for the treatment of moderate-to-severe atopic dermatitis (eczema) in adults and children aged 12
To treat cardiometabolic illnesses, Novo Nordisk will develop RNA editing candidates for two targets using Korro Bio's OPERA technology On September 16, 2024, Korro Bio, a Massachusetts-based biopharmaceutical company that develops genetic therapeutics based on RNA editing, announced a collaboration with Novo Nordisk to discover targets to treat
The new Vivaflow SU tangential flow filtration cassette also provides improved ultrafiltration and diafiltration efficiency Sartorius has launched its Vivaflow SU tangential flow filtration (TFF) cassette on September 9, 2024. The new TFF cassette is made for straightforward use and adaptability in the lab, providing more efficient and sustainable ultrafiltration
This is the company's greatest investment in the Sweden Biomanufacturing Center in Södertälje AstraZeneca has announced a new investment of about US $135 million, which is around 1.375 billion Swedish krona, into its Biomanufacturing Center located in Södertälje, according to a press release dated Aug. 26, 2024.
On Aug. 14, 2024, the World Health Organization (WHO) declared mpox (previously called monkeypox) as a public health emergency of international concern (PHEIC) due to the rising infection rates observed in African countries. The International Health Regulations Emergency Committee, consisting of independent experts, has provided guidance to the World Health
Prior approvals for PiaSky (crovalimab) include those for monthly subcutaneous use in the US and Japan, where users with sufficient training may be able to self-administer the medication Roche announced in a press release on Aug. 27, 2024 that PiaSky (crovalimab) has received approval from the European Commission (EC) for
Opaganib has been granted orphan drug designation for the treatment of neuroblastoma in children RedHill Biopharma, based in Tel Aviv, has received orphan drug designation from the FDA for Opaganib. This drug is a proprietary and investigational host-directed treatment for neuroblastoma, a type of cancer that primarily affects infants, with
Novartis acquired Chinook Therapeutics a little more than a year ago, and this collaboration builds on that On Aug. 22, 2024, a press release was issued to announce the collaboration between Novartis and Versant Ventures in the establishment of Borealis Biosciences, an independent biotechnology company focused on early-stage research. The
The licenses and authorizations coincide with a late summer rise of the virus, which is tracking somewhat sooner than the early fall wave in the United States in 2023 The FDA has recently given its approval and Emergency Use Authorization (EUA) for the latest formulas of messenger RNA (mRNA) vaccines
NexoBrid, a biological product that can be applied topically, has been approved for use in all age groups in the United States, European Union, and Japan MediWound, a company based in Yavne, Israel, announced on Aug. 15, 2024, that their product NexoBrid (anacaulase-bcdb) has received FDA approval for treating deep
Every year, the infectious virus causes up to 160,000 hospitalizations and up to 13,000 deaths in the United States Pfizer recently shared encouraging news about the safety and effectiveness of Abrysvo, their approved vaccine for respiratory syncytial virus (RSV). The results from a substudy of a Phase III